hypercalcemia

DEFINITION of hypercalcemia

hypercalcemia is an abnormally elevated level of calcium in the blood serum, distinguished from hypocalcemia, the opposite state of abnormally low serum calcium. It results from increased bone resorption, increased intestinal calcium absorption, decreased renal calcium excretion, or a combination of these mechanisms, most often mediated by excess parathyroid hormone (PTH), parathyroid hormone-related protein (PTHrP), or vitamin D activity. It can be mild and transient (e.g., dehydration-related hemoconcentration, thiazide diuretic use) versus pathological and progressive, most commonly driven by primary hyperparathyroidism (the leading cause in outpatient/ambulatory settings) or malignancy (the leading cause in hospitalized inpatients, via PTHrP secretion from solid tumors, osteolytic bone metastases, or ectopic calcitriol production in lymphoma). Clinically relevant forms encountered in coding include hypercalcemia due to disorders of calcium metabolism (E83.52), hypercalcemia secondary to hyperparathyroidism (E21.0-E21.3), and hypercalcemia of malignancy, which is coded to the underlying or metastatic neoplasm plus E83.52. Severe, symptomatic hypercalcemia (serum calcium generally >14 mg/dL with altered mental status, dehydration, or renal impairment) constitutes a hypercalcemic crisis and is a medical emergency requiring aggressive IV hydration and antiresorptive therapy. hypercalcemia is commonly confused with hyperparathyroidism, which is the glandular disease process itself (a cause), whereas hypercalcemia is the laboratory/clinical finding (an effect) — the two are coded separately and both should be captured when documented.

---

ETYMOLOGY of hypercalcemia

greek | latin

Component	Origin	Meaning
hyper-	Greek hyper (ὑπέρ)	“over,” “above,” “excess” — intensifying/directional prefix indicating a state above normal
calc-	Latin calx, calcis (“lime, limestone”); Neo-Latin calcium, coined 1808 by Humphry Davy upon isolating the element	”calcium,” “lime” — combining form referring to the mineral calcium
-emia	Greek haima (αἷμα, “blood”) via New Latin -aemia	Noun-forming suffix — “condition of the blood”

The word entered medical English in the early 20th century as hypercalcemia (noun), built from hyper- + the New Latin combining form calc- (from calcium, itself coined from Latin calx) + the Greek-derived suffix -emia — literally “excess calcium in the blood.” The root calc- connects hypercalcemia to a family of clinically related terms: hypocalcemia (deficient blood calcium), hypercalciuria (excess calcium in the urine), and calcinosis (abnormal calcium deposition in soft tissue). The suffix -emia is highly productive in medical terminology and appears in numerous related blood-condition terms: hyperglycemia, hypokalemia, anemia, uremia, hyperlipidemia.

---

🔀 ALIASES / ALTERNATE TERMS

• Hypercalcaemia (British/alternate spelling; identical clinical meaning)
• Elevated serum calcium (descriptive lay/clinical synonym often used in lab result documentation)
• Hypercalcemic crisis (severe, acute, symptomatic form — endocrine emergency; not a distinct ICD-10-CM code, coded as E83.52 with severity captured in documentation)
• Hypercalcemia of malignancy (HCM) (etiologic subtype seen in oncology/inpatient settings; code the neoplasm first, then E83.52)
• Humoral hypercalcemia of malignancy (HHM) (PTHrP-mediated subtype, most common paraneoplastic form, especially with squamous cell carcinomas)
• Milk-alkali syndrome (etiologic subtype from excessive calcium/absorbable alkali intake; coded as E83.52 with the causative substance captured via a T-code when medication/supplement-induced)

---

🔗 RELATED TERMS

• hypocalcemia — the opposite of hypercalcemia; abnormally low serum calcium, most often from hypoparathyroidism, vitamin D deficiency, or renal disease; coded to E83.51
• hypercalciuria — shares the calc- root; excess calcium excretion in the urine, a distinct disorder from hypercalcemia though the two frequently coexist
• hyperparathyroidism — the most common outpatient cause of hypercalcemia; excess PTH secretion from one or more parathyroid glands; primary form coded E21.0
• hypercalcemia of malignancy — a paraneoplastic or metastatic complication of cancer; code the malignancy first, then E83.52; common comorbid diagnoses include bone metastases, multiple myeloma, and squamous cell carcinoma
• PTH-related protein (PTHrP) — the mechanism underlying most humoral hypercalcemia of malignancy; a hormone-like peptide secreted by tumor cells that mimics PTH activity at bone and kidney
• osteolysis — the cellular/bone-resorptive mechanism by which localized bone metastases release calcium into the bloodstream, contributing to local osteolytic hypercalcemia
• hypervitaminosis D — excess vitamin D activity causing increased intestinal calcium absorption and hypercalcemia; coded E67.3
• sarcoidosis — a granulomatous disease that can cause hypercalcemia via ectopic, unregulated calcitriol (activated vitamin D) production by macrophages within granulomas
• nephrocalcinosis — a renal complication of chronic hypercalcemia from calcium deposition in the renal parenchyma
• parathyroidectomy — the primary diagnostic/therapeutic procedure associated with hyperparathyroidism-driven hypercalcemia when medical management fails

---

CODING CORNER

🏥 ICD-10-CM CODES

Hypercalcemia (E83.5x — Disorders of Calcium Metabolism)

Code	Description
E83.52	Hypercalcemia
E83.51	Hypocalcemia (opposite finding; include only if concurrently documented)
E83.59	Other disorders of calcium metabolism

Hyperparathyroidism (Common Etiologic Cause — E21.0-E21.3)

Code	Description
E21.0	Primary hyperparathyroidism
E21.1	Secondary hyperparathyroidism, not elsewhere classified
E21.2	Other hyperparathyroidism
E21.3	Hyperparathyroidism, unspecified

Other Etiologic/Associated Codes

Code	Description
E67.3	Hypervitaminosis D
C79.51	Secondary malignant neoplasm of bone (use when hypercalcemia is due to osteolytic bone metastases; sequence per underlying malignancy guidelines)
C90.00	Multiple myeloma, not having achieved remission (common cause of malignancy-related hypercalcemia)

---

🔧 COMMON CPT CODES (Hypercalcemia-Related Diagnosis & Treatment)

CPT Code	Description
82310	Calcium; total
82330	Calcium; ionized
83970	Parathyroid hormone (PTH)
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed
82652	Vitamin D; 1, 25 dihydroxy, includes fraction(s), if performed
78070	Parathyroid planar imaging (including subtraction, when performed)
78072	Parathyroid planar imaging with tomographic (SPECT) and concurrently acquired CT
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour
96361	Intravenous infusion, hydration; each additional hour
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance/drug
60500	Parathyroidectomy or exploration of parathyroid(s)
60502	Parathyroidectomy or exploration of parathyroid(s); re-exploration
60505	Parathyroidectomy or exploration of parathyroid(s); with mediastinal exploration, sternal split or transthoracic approach

HCPCS Level II (plain text — not wikilinked):

• J3489 — Injection, zoledronic acid (bone-modifying agent, first-line for hypercalcemia of malignancy)
• J0897 — Injection, denosumab (used in bisphosphonate-refractory or renal-impaired patients)
• J0630 — Injection, calcitonin-salmon (rapid-onset, short-duration adjunct for severe/symptomatic hypercalcemia)

---

⚠️ Coding Note: hypercalcemia (E83.52) does not require laterality or site specificity, but sequencing matters: when hypercalcemia is due to an underlying condition such as primary hyperparathyroidism or malignancy, coding guidelines generally direct sequencing the underlying etiology first (e.g., E21.0 or the malignancy code) with E83.52 as a secondary/manifestation code, unless the hypercalcemia itself is the primary reason for the encounter or admission — review the “code first” and sequencing notes in the current ICD-10-CM tabular list for E83.5x and E21.x, and always confirm with the payer-specific or facility-specific sequencing policy. On inpatient profee claims, watch for undercoding when documentation reads “elevated calcium” or “high calcium” without the term “hypercalcemia” explicitly stated — a physician query may be warranted to confirm the clinical significance before assigning E83.52. Malignancy-associated hypercalcemia should never be coded with E83.52 alone; the causative neoplasm code is required and typically sequenced first per chapter-specific neoplasm coding guidelines. If a bisphosphonate, calcitonin, or other agent is implicated in drug-induced hypercalcemia (e.g., thiazide diuretics, lithium, vitamin D/calcium supplementation), a companion T-code with the correct 7th character (initial encounter, subsequent encounter, or sequela) is required to capture the adverse effect or poisoning.

---

DERIVATIONS of hypercalcemia

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[hypercalcemia]].roots, word))) > 0 AND file.name != [[hypercalcemia]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[hypercalcemia]].definition, word))) > 0 AND file.name != [[hypercalcemia]].file.name

Med terms dictionary Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms